The Kansas Legislature is currently considering a bill, SB 284, under seemingly noble pretense. Proponents of SB 284 argue ...
A new pilot program from the federal government has hospital and pharmacy leaders bracing for what they describe as a fundamental dismantling of the ...
If HHS' 340B rebate model pilot proceeds as planned, more than 2,700 U.S. hospitals will collectively be saddled with approximately $400 million ...
Ryan Long, the co-author of a recent USC Schaeffer Center white paper on the 340B Drug Pricing Program, argues that meaningful reform requires shifting to a direct subsidy model based on need.
The 340B drug discount program incentivizes hospitals to purchase outpatient clinics and prescribe more and higher-cost drugs — behaviors that tend to increase costs for the federal government and ...
The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s estimates, and HRSA should delay the program’s ...
One of the world’s biggest drug makers is suing the country’s smallest state. The argument is over a federal drug discount program ...
AHA comments on the Health Resources and Services Administration’s (HRSA) information collection request (ICR) regarding the expected costs of its 340B Rebate Model Pilot Program.
New York state lawmakers are considering a bill that'd make it easier for big hospital systems to siphon off financial aid that's meant for poor patients. The bill involves the 340B Drug Pricing ...
A bipartisan group of lawmakers has sent a letter to the Department of Health and Human Services, asking the agency to cancel an upcoming rebate pilot for drugs purchased by hospitals under the 340B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback